Seq-Scope-X Revolutionizes Gene Mapping in Tissues with Unprecedented Precision

Researchers at the University of Michigan have unveiled Seq-Scope-eXpanded (Seq-Scope-X), a breakthrough in spatial transcriptomics. The new technology builds on the original Seq-Scope method, developed in 2021, to map gene activity in tissues with far greater precision.

This advancement allows scientists to examine individual cells and their subcellular environments in unprecedented detail, pushing past previous technical barriers.

The original Seq-Scope technology enabled large-scale mapping of mRNA molecules within intact tissues. However, its spatial resolution was constrained by physical limits, such as molecular diffusion barriers.

Seq-Scope-X overcomes these challenges by combining tissue expansion techniques with Illumina sequencing platforms. Tissues are embedded in hydrogels and expanded isotropically, physically enlarging samples before analysis. This process improves the differentiation of individual cells and the tracing of gene expression patterns at a subcellular level.

To handle the increased data complexity, the team also developed new computational tools. These methods help interpret the high-resolution spatial transcriptomic data generated by the expanded tissues. The result is a nearly tenfold improvement in resolution compared to earlier approaches.

The researchers emphasise the technology's broad potential across fields like cancer biology, developmental biology, and neuroscience. They are now focused on refining Seq-Scope-X for wider adoption, aiming to transition it from laboratory research to practical applications.

Seq-Scope-X marks a significant leap in spatial transcriptomics, enabling finer mapping of gene expression within tissues. The method's enhanced resolution and computational support open doors for deeper biological insights. The team continues to work on making the technology more accessible for research and clinical use.